HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The protective effects of D-600 and propranolol on reperfusion injury in the anaesthetized rabbit.

Abstract
The ability of a calcium channel blocker (D-600) and a beta-adrenergic antagonist (propranolol) to modify the chemical, biochemical, functional, and ultrastructural manifestations of reperfusion injury following circumflex coronary artery ligation has been examined using an open chest, anaesthetized rabbit model of acute myocardial ischaemia. A 40-min ligation period followed by 60 min of reperfusion produced a decrease in mitochondrial azide-sensitive ATPase activity which could be prevented by pretreatment with either agent. While both drugs caused an equivalent (approximately 50%) reduction in myocardial Ca2+ accumulation associated with reperfusion, only D-600 preserved Mg2+ and Na+ levels. The greater protective effects of D-600 on sarcolemmal integrity were also apparent from its superior ability (when compared with propranolol) to offer protection against the loss of sarcolemmal Na+-K+ ATPase activity which we have previously suggested may parallel the development of irreversible ischaemic injury. Further support for these biochemical data came from ultrastructural studies in which we demonstrated significant improvement in subcellular membrane integrity by both of the drugs. In contrast to the foregoing protective actions, D-600 and propranolol failed to prevent the marked decrease in myocardial contractile function and in cellular ATP content associated with reperfusion. The superior effectiveness of D-600 in our system cannot be explained on the basis of Ca2+ antagonism alone, but is more likely a result of its greater negative inotropism.
AuthorsM M Moore, D V Godin
JournalCanadian journal of physiology and pharmacology (Can J Physiol Pharmacol) Vol. 62 Issue 2 Pg. 212-23 (Feb 1984) ISSN: 0008-4212 [Print] Canada
PMID6324979 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ions
  • Gallopamil
  • Adenosine Triphosphate
  • Propranolol
  • Verapamil
  • 4-Nitrophenylphosphatase
  • Sodium-Potassium-Exchanging ATPase
Topics
  • 4-Nitrophenylphosphatase (metabolism)
  • Adenosine Triphosphate (metabolism)
  • Anesthesia
  • Animals
  • Coronary Circulation
  • Gallopamil (therapeutic use)
  • Heart (drug effects)
  • Ions (metabolism)
  • Male
  • Membranes (physiology)
  • Myocardial Contraction (drug effects)
  • Myocardium (enzymology)
  • Propranolol (therapeutic use)
  • Rabbits
  • Sarcolemma (enzymology)
  • Sodium-Potassium-Exchanging ATPase (metabolism)
  • Subcellular Fractions (physiology)
  • Verapamil (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: